SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,551 Cr | ₹1,370 Cr | ₹1,421 Cr | ₹1,413 Cr | ₹1,362 Cr |
What is the latest Revenue of SEQUENT SCIENTIFIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,551 Cr |
| Mar2024 | ₹1,370 Cr |
| Mar2023 | ₹1,421 Cr |
| Mar2022 | ₹1,413 Cr |
| Mar2021 | ₹1,362 Cr |
How is Revenue of SEQUENT SCIENTIFIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,551 Cr | 13.26 | |
| Mar2024 | ₹1,370 Cr | -3.60 | |
| Mar2023 | ₹1,421 Cr | 0.57 | |
| Mar2022 | ₹1,413 Cr | 3.76 | |
| Mar2021 | ₹1,362 Cr | - | |
Compare Revenue of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹5,614.4 Cr | -10.4% | 9.1% | 22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -10.4% |
9.1% |
22.2% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses